ClinicalTrials.Veeva

Menu

The Effect of Anesthetic Technique on VEGF-C and PGE2

G

General Hospital of Ningxia Medical University

Status

Completed

Conditions

Uterine Leiomyomas

Treatments

Other: spinal anesthesia and continuous postoperative epidural analgesia
Other: general anesthesia and patient controlled intravenous analgesia

Study type

Interventional

Funder types

Other

Identifiers

NCT02829333
Zhangyonghai001

Details and patient eligibility

About

The purpose of this study is to verify the effect of anesthetic technique on the change of postoperative serum vascular endothelial growth factor C and prostaglandin E2, and to explore the potential impact of the anesthetic technique on leiomyomas recurrence and growth after the surgery of abdominal myomectomy.

Full description

Uterine leiomyomas is the most common benign tumor of uterus, the most common tumor in women as well. Like many other forms of tumor, it requires an independent blood supply to enlarge. This process, angiogenesis, is mediated by vascular endothelial growth factor C (VEGF-C) and prostaglandin E2 (PGE2). Several studies have confirmed that VEGF-C has a high level in patients with uterine leiomyomas, which has also been demonstrated that it was related to occurrence and growth of uterine leiomyomas because it's capable of promoting angiogenesis, mitogenic, and vascular permeability-enhancing activities. Also, some researchers suggested that suppression of prostaglandin synthesis (including PGE2) via cyclooxygenase type-2 (COX-2) enzyme inhibition may reduce the incidence of some tumor. The aim of this study is to verify the effect of anesthetic technique on the change of postoperative serum VEGF-C and PGE2, and to explore the potential impact of the anesthetic technique on leiomyomas recurrence and growth after the surgery of abdominal myomectomy.

Enrollment

44 patients

Sex

Female

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patients with leiomyomas requiring abdominal myomectomy, aged 18-65 year and American Society of Anesthesiologists (ASA) physical status I or II.

Exclusion criteria

  • The patients who had a history of surgery within the preceding two weeks, a history of blood transfusion and a history of coronary artery disease, any contraindication to spinal anesthesia or opioid analgesia.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

44 participants in 2 patient groups

Group GA
Other group
Description:
22 patients receive general anesthesia and patient controlled intravenous analgesia
Treatment:
Other: general anesthesia and patient controlled intravenous analgesia
Group SA
Other group
Description:
22 patients receive spinal anesthesia and continuous postoperative epidural analgesia
Treatment:
Other: spinal anesthesia and continuous postoperative epidural analgesia

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems